Skip to main content

Production Process for Stem Cell Based Therapeutic Implants: Expansion of the Production Cell Line and Cultivation of Encapsulated Cells

  • Chapter
  • First Online:
Bioreactor Systems for Tissue Engineering II

Abstract

Cell based therapy promises the treatment of many diseases like diabetes mellitus, Parkinson disease or stroke. Microencapsulation of the cells protects them against host-vs-graft reactions and thus enables the usage of allogenic cell lines for the manufacturing of cell therapeutic implants. The production process of such implants consists mainly of the three steps expansion of the cells, encapsulation of the cells, and cultivation of the encapsulated cells in order to increase their vitality and thus quality. This chapter deals with the development of fixed-bed bioreactor-based cultivation procedures used in the first and third step of production. The bioreactor system for the expansion of the stem cell line (hMSC-TERT) is based on non-porous glass spheres, which support cell growth and harvesting with high yield and vitality. The cultivation process for the spherical cell based implants leads to an increase of vitality and additionally enables the application of a medium-based differentiation protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lanza RP, Hayes JL, Chick WL (1996) Encapsulated cell technology. Nature Biotech 14:1107–1111

    Article  CAS  Google Scholar 

  2. Freimark D, Czermak P (2009) Cell-based regeneration of intervertebral disc defects: review and concepts. Int J Artif Organs 32:197–203

    Google Scholar 

  3. Baksh D, Song L, Tuan RS (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301–316

    Article  CAS  Google Scholar 

  4. Chiu RCJ (2003) Bone-marrow stem cells as a source for cell therapy. Heart Failure Rev 8:247–251

    Article  Google Scholar 

  5. Fraser JK et al (2004) Adult stem cell therapy for the heart. Int J Biochem Cell Biol 36:658–666

    Article  CAS  Google Scholar 

  6. Mimeault M, Hauke R, Batra SK (2007) Stem cells: a revolution in therapeutics–recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82:252–264

    Article  CAS  Google Scholar 

  7. Simonsen JL et al (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592–596

    Article  CAS  Google Scholar 

  8. Heile AMB et al (2009) Cerebral Q1 transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci Lett

    Google Scholar 

  9. Aris R (1975) The mathematical theory of diffusion and reaction impermeable catalysts. Clarendon, Oxford

    Google Scholar 

  10. Bailey J, Ollis DF (1986) Biochemical engineering fundamentals. McGraw-Hill, New York

    Google Scholar 

  11. Froment GF, Bischoff KB (1979) Chemical reactor analysis and design. Wiley, New York

    Google Scholar 

  12. Fassnacht D (2001) Fixed-bed reactors for the cultivation of animal cells. Fortschritt-Berichte VDI, vol. 17, VDI-Verlag, Düsseldorf

    Google Scholar 

  13. Willaert RG, Baron GV, de Backer L (1996) Modelling of immobilised bioprocesses. In: Willaert RG, Baron GV, de Backer L (eds) Immobilised living cell systems. Wiley, New York, pp 237–254

    Google Scholar 

  14. Perry RH, Green DW (2007) Perry’s chemical engineers’ handbook. McGraw-Hill

    Google Scholar 

  15. Weber C, Gokorsch S, Czermak P (2007) Expansion and chondrogenic differentiation of human mesenchymal stem cells. Int J Artif Organs 30:611–618

    CAS  Google Scholar 

  16. Schop D et al (2009) Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng A 15:1877–1886

    Article  CAS  Google Scholar 

  17. Higuera G et al (2009) Qvantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model. Tissue Eng Part A 15:1–11

    Article  Google Scholar 

  18. Schop D et al (2008) Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism. J Tissue Eng Regen Med 2:126–135

    Article  CAS  Google Scholar 

  19. Lonergan T, Brenner C, Bavister B (2006) Differentiation-related changes in mitochondrial properties as indicators of stem cell competence. J Cell Phys 208:149–153

    Article  CAS  Google Scholar 

  20. Conget P, Minguell JJ (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Phys 181:67–73

    Article  CAS  Google Scholar 

  21. Guo Z et al (2001) Biological features of mesenchymal stem cells from human bone marrow. Chin Med J 114:950–953

    CAS  Google Scholar 

  22. Soukup T et al (2006) Mesenchymal stem cells isolated from human bone marrow: cultivation, phenotypic analysis and changes in proliferation kinetics. Acta Med 49:27–33

    Google Scholar 

  23. Peng CA, Palson BA (1996) Determination of specific oxygen uptake rates in human hematopoietic cultures and implications for bioreactor design. Ann Biomed Eng 24:373–381

    Article  CAS  Google Scholar 

  24. Pörtner R et al (2005) Bioreactor design for tissue engineering. J Biosci Bioeng 100:235–245

    Article  Google Scholar 

  25. Acevedo CA et al (2008) A mathematical model for the design of fibrin microcapsules with skin cells. Bioprocess Biosyst Eng 32(3):341–351

    Article  Google Scholar 

  26. De Leon A, Mayani H, Ramırez OT (1998) Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions. Cytotechnol 28:127–138

    Article  Google Scholar 

  27. Youn BS, Sen A, Behie LA (2006) Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors. Biotechnol Prog 22:801–810

    Article  CAS  Google Scholar 

  28. Weber C et al (2007) Cultivation and differentiation of encapsulated hMSC-TERT in a disposable small-scale syringe-like fixed bed reactor. Open Biomed Eng J 1:64–70

    CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Federal Ministry of Economics and Technology for financial support as well as the CellMed AG for providing the production cell line hMSC-TERT and the CellBeads®.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Czermak .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Weber, C. et al. (2010). Production Process for Stem Cell Based Therapeutic Implants: Expansion of the Production Cell Line and Cultivation of Encapsulated Cells. In: Kasper, C., van Griensven, M., Pörtner, R. (eds) Bioreactor Systems for Tissue Engineering II. Advances in Biochemical Engineering / Biotechnology, vol 123. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_2009_25

Download citation

Publish with us

Policies and ethics